Tekla Capital Management LLC Sangamo Therapeutics, Inc Transaction History

Tekla Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$9.38 - $12.48 $1.41 Million - $1.87 Million	-149,835 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$8.03 - $11.7 $1.2 Million - $1.75 Million	149,835 New	149,835 $1.25 Million
Q3 2019 Nov 13, 2019	SELL	$9.05 - $12.22 $1.09 Million - $1.48 Million	-120,768 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$8.75 - $13.03 $1.06 Million - $1.57 Million	-120,770 Reduced 50.0%	120,768 $1.3 Million
Q4 2018 Feb 13, 2019	BUY	$9.51 - $16.6 $662,361 - $1.16 Million	69,649 Added 40.52%	241,538 $2.77 Million
Q3 2018 Nov 13, 2018	BUY	$13.05 - $19.05 $670,469 - $978,731	51,377 Added 42.63%	171,889 $2.91 Million
Q2 2018 Aug 13, 2018	BUY	$13.9 - $19.8 $1.68 Million - $2.39 Million	120,512 New	120,512 $1.71 Million

133

86.3M

35.9K

156K

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $136M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tekla Capital Management LLC with notifications on news.